The Group is a well-recognized biotech company, our business operations have been spread throughout over 100 countries worldwide with our legal entities located in the United States, Mainland China, Hong Kong, Japan, Singapore, Netherlands and Ireland. Deeply rooted in our proprietary gene synthesis technology and the advancement of research and application of our core technology and know-hows, we have well established four major platforms including (i) the leading contracted research organization (the “CRO” ) platform to provide one-stop solutions to global research communities; (ii) the contract development and manufacturing organization (the “CDMO” ) platform; (iii) the industrial synthetic products platform; and (iv) the integrated global cell therapy platform. The above four internally-built platforms have demonstrated their rapid growth from research and development and commercial delivery perspectives during the Reporting Period respectively.